Published in J Hepatol on November 24, 2009
Integrating cellular metabolism into a multiscale whole-body model. PLoS Comput Biol (2012) 1.01
Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. Orphanet J Rare Dis (2014) 0.87
Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol (2013) 0.83
Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency. Dis Model Mech (2013) 0.81
Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update. J Genet Genomics (2015) 0.79
Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature. Case Rep Med (2016) 0.76
A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation. PLoS One (2015) 0.75
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Medical sequencing at the extremes of human body mass. Am J Hum Genet (2007) 5.61
Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med (2005) 4.07
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med (2011) 3.79
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr (2006) 3.45
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab (2010) 2.99
Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr (2006) 2.73
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med (2009) 2.53
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
For the law, neuroscience changes nothing and everything. Philos Trans R Soc Lond B Biol Sci (2004) 2.46
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. Pediatr Res (2009) 2.28
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Sepsis: time to reconsider the concept. Crit Care Med (2008) 2.17
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2009) 2.13
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet (2004) 2.04
Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med (2006) 2.04
Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nat Genet (2010) 2.00
A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock (2005) 1.97
Training with the compactEASIE biologic endoscopy simulator significantly improves hemostatic technical skill of gastroenterology fellows: a randomized controlled comparison with clinical endoscopy training alone. Gastrointest Endosc (2005) 1.96
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis (2005) 1.91
A systematic review of population screening for fragile X syndrome. Genet Med (2010) 1.87
Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Isr Med Assoc J (2005) 1.82
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81
Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ (2008) 1.73
Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia. Nat Genet (2003) 1.71
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother (2006) 1.70
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet (2002) 1.69
Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc (2011) 1.69
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet (2004) 1.66
A large Q fever outbreak in an urban school in central Israel. Clin Infect Dis (2010) 1.62
Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet (2009) 1.61
Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med (2008) 1.57
A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet (2005) 1.51
Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med (2003) 1.51
Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr (2006) 1.50
Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet (2008) 1.49
Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (2006) 1.46
Addressing the educational void during the antiretroviral therapy rollout. AIDS (2004) 1.45
Prenatal brain disruption in molybdenum cofactor deficiency. J Child Neurol (2011) 1.45
Malaria in travelers returning from short organized tours to holiday resorts in Mombassa, Kenya. Isr Med Assoc J (2005) 1.45
HIV testing experiences among male and female inmates in Rhode Island. AIDS Read (2007) 1.45
Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med (2015) 1.45
Bacterial expression of mutant argininosuccinate lyase reveals imperfect correlation of in-vitro enzyme activity with clinical phenotype in argininosuccinic aciduria. J Inherit Metab Dis (2011) 1.44
Comparison of metabolic monitors in critically ill, ventilated patients. Nutrition (2006) 1.44
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Gastrointest Endosc (2006) 1.42
Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (2006) 1.42
Infective endocarditis in diabetic and non-diabetic patients. Scand J Infect Dis (2004) 1.42
Myeloid dysplasia in familial 3-methylglutaconic aciduria. J Pediatr Hematol Oncol (2006) 1.42
Nonsyndromic paucity of interlobular bile ducts: report of 10 patients. J Pediatr Gastroenterol Nutr (2003) 1.41
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis (2007) 1.36
Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet (2011) 1.36
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol (2005) 1.32
Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med (2006) 1.32
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol (2006) 1.30
"Opt-out" testing for HIV in Africa: a caution. Lancet (2004) 1.30
ERCP core curriculum. Gastrointest Endosc (2006) 1.30
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit Care (2013) 1.29
Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides. Ther Clin Risk Manag (2008) 1.27
Clinical and molecular genetic features of ARC syndrome. Hum Genet (2006) 1.26
The less they know, the better: abstinence-only HIV/AIDS programs in Uganda. Reprod Health Matters (2006) 1.25
Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. J Immunol (2002) 1.25
The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol (2002) 1.24
Health benefits of legal services for criminalized populations: the case of people who use drugs, sex workers and sexual and gender minorities. J Law Med Ethics (2010) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics (2011) 1.17
Excellence in endoscopy: toward practical metrics. Gastrointest Endosc (2006) 1.15
A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Mol Genet Metab (2005) 1.15
Predictors of stress in mothers and fathers of children with fragile X syndrome. Res Dev Disabil (2005) 1.13
Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs. J Acquir Immune Defic Syndr (2010) 1.12
Lives to save: PEPFAR, HIV, and injecting drug use in Africa. Lancet (2009) 1.11
When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients. Mol Genet Metab (2006) 1.11
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun (2011) 1.10
Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Hum Genet (2013) 1.09
Readmission to the intensive care unit after "fast-track" cardiac surgery: risk factors and outcomes. Ann Thorac Surg (2003) 1.09
The significance of isolated elevation of serum aminotransferases in infants and young children. Arch Dis Child (2007) 1.08
The Neo-Papilla: a new modification of porcine ex vivo simulators for ERCP training (with videos). Gastrointest Endosc (2006) 1.07
Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06
Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr (2002) 1.06
Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1. Am J Med Genet A (2013) 1.04
Changes in regional distribution of lung sounds as a function of positive end-expiratory pressure. Crit Care (2009) 1.04
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.04
Monetary benefits of preventing childhood lead poisoning with lead-safe window replacement. Environ Res (2007) 1.03
Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc (2014) 1.03
Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg (2004) 1.02
SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Ann Neurol (2009) 1.02
Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997. Emerg Infect Dis (2003) 1.01
Mutations in SDHD lead to autosomal recessive encephalomyopathy and isolated mitochondrial complex II deficiency. J Med Genet (2013) 1.01
Infantile cerebral and cerebellar atrophy is associated with a mutation in the MED17 subunit of the transcription preinitiation mediator complex. Am J Hum Genet (2010) 1.01